Metoprolol in Critically Ill Patients With COVID-19
Randomized Controlled Trial
[키워드] Activated neutrophils
acute care
acute respiratory distress
administration
alleviate
alveolar
alveolar inflammation
appear
ARDS
BAL
baseline
Bronchoalveolar lavage
control group
control groups
control subjects
coronavirus
COVID
COVID-19
COVID-19 pandemic
COVID-19 patient
COVID-19-associated ARDS
evaluate the effect
evaluated
exacerbated
groups
hemodynamic
Ill
infiltration
Inflammation
intravenous
invasive
Invasive mechanical ventilation
Lung inflammation
marker
metoprolol
metoprolol.
Myocardial infarction
neutrophil
Neutrophil extracellular trap
not differ
Oxygenation
PaO
Patient
patients randomized
Randomized
reduced
remained
repurposing
Respiratory function
Safe
shown
Side effects
significantly
syndrome
Treatment
Trial
[DOI] 10.1016/j.jacc.2021.07.003 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1016/j.jacc.2021.07.003 PMC 바로가기 [Article Type] Randomized Controlled Trial